Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / ISIN
-
Number of holders
-
202
-
Total shares
-
130M
-
Shares change
-
+13.1M
-
Total reported value, excl. options
-
$204M
-
Value change
-
+$20.3M
-
Put/Call ratio
-
0.73
-
Number of buys
-
94
-
Number of sells
-
-56
-
Price
-
$1.57
Significant Holders of SORRENTO THERAPEUTICS INC - ISIN (SRNE) as of Q3 2022
205 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - ISIN as of Q3 2022.
SORRENTO THERAPEUTICS INC - ISIN (SRNE) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130M shares
.
Largest 10 shareholders include STATE STREET CORP (40.7M shares), VANGUARD GROUP INC (22.5M shares), GEODE CAPITAL MANAGEMENT, LLC (7.11M shares), D. E. Shaw & Co., Inc. (5.06M shares), NORTHERN TRUST CORP (3.44M shares), JPMORGAN CHASE & CO (3.03M shares), GOLDMAN SACHS GROUP INC (3.01M shares), Rafferty Asset Management, LLC (2.99M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.94M shares), and NORGES BANK (2.9M shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.